NCT06814379

Brief Summary

More than half of patients with post-COVID-19 syndrome experience fatigue. Rehabilitation is needed to treat this persistent symptom. The aim of this study is to conduct a rehabilitation intervention to treat patients with post-COVID-19 syndrome who experience persistent fatigue.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 28, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

February 3, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 7, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2025

Completed
Last Updated

January 26, 2026

Status Verified

February 1, 2025

Enrollment Period

6 months

First QC Date

January 28, 2025

Last Update Submit

January 23, 2026

Conditions

Keywords

COVID-19post-COVID-19 syndromefatigue

Outcome Measures

Primary Outcomes (4)

  • Perceived Fatigue

    To assess perceived fatigue using the borg modified scale.The scale ranges from 0 to 10, with higher scores indicating greater fatigue perception.

    Through study completion, an average of 1 year

  • Multidimensional Fatigue

    To assess multidimensional fatigue using the multidimensional fatigue inventory MFI-20). The scale comprises five subscales (General Fatigue, Physical Fatigue, Mental Fatigue, Reduced Activity, and Reduced Motivation), each ranging from 4 to 20 points. Higher scores indicate greater fatigue.

    Through study completion, an average of 1 year

  • Fatigue Severity

    To assess fatigue severity using the fatigue severity scale (FSS). The total score ranges from 7 to 63 points, with higher scores indicating greater fatigue severity. A score of ≥36 is considered indicative of significant fatigue.

    Through study completion, an average of 1 year

  • Fatigue Impact

    To assess fatigue impact using the Modified Fatigue Impact Scale (MFIS). Scores range from 0 to 36, with higher scores indicating a greater impact of fatigue on daily activities.

    Through study completion, an average of 1 year

Secondary Outcomes (24)

  • COVID-19 information

    Through study completion, an average of 1 year

  • Comorbidities

    Through study completion, an average of 1 year

  • Dyspnea. The Borg Modified Scale

    Through study completion, an average of 1 year

  • Dyspnea. Dyspnea-12

    Through study completion, an average of 1 year

  • Dyspnea. Modified Medical Research Council (mMRC) Dyspnea Scale

    Through study completion, an average of 1 year

  • +19 more secondary outcomes

Study Arms (3)

Control group

NO INTERVENTION

Not intervention

Rehabilitation

EXPERIMENTAL

30-60 minutes. A total of 3 session/week at home. 4 weeks. * Warm-up. * Aerobic: walking (20-25 minutes). * Strength: (25-30 minutes). * Cooling. * Education: WHO recommendations.

Behavioral: Rehabilitation

Virtual reality based rehabilitation

EXPERIMENTAL

30-60 minutes. A total of 3 session/week (2 sessions at home and 1 session at the University of Granada). 4 weeks. The 2 sessions at home will be the same as the sessions in the rehabilitation group (group 2). The session at the University of Granada will be done with virtual reality (Nintendo Switch) and will follow the same outline as the rest of the sessions: * Warm-up. * Aerobic: walking (20-25 minutes). * Strength: (25-30 minutes). * Cooling. * Education: WHO recommendations.

Behavioral: Virtual reality based rehabilitation

Interventions

RehabilitationBEHAVIORAL

30-60 minutes. A total of 3 session/week at home. 4 weeks. * Warm-up. * Aerobic: walking (20-25 minutes). * Strength: (25-30 minutes). * Cooling. * Education: WHO recommendations.

Rehabilitation

30-60 minutes. A total of 3 session/week (2 sessions at home and 1 session at the University of Granada). 4 weeks. The 2 sessions at home will be the same as the sessions in the rehabilitation group (group 2). The session at the University of Granada will be done with virtual reality (Nintendo Switch) and will follow the same outline as the rest of the sessions: * Warm-up. * Aerobic: walking (20-25 minutes). * Strength: (25-30 minutes). * Cooling. * Education: WHO recommendations.

Virtual reality based rehabilitation

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of COVID-19
  • post-COVID-19 syndrome
  • adults ≥ 18 y \< 75 años
  • be medically stable
  • to be able to walk
  • not currently participating in a rehabilitation programme and/or other study.
  • fatigue: FSS ≥ 36 puntos
  • basic knowledge
  • wish to participate in the study and sign the informed consent

You may not qualify if:

  • patients with severe comorbidities that interfere with the ability to perform the study
  • patients with mental, physical or organic problems that under medical criteria may pose a risk to the patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Granada

Granada, Granada, 18016, Spain

Location

MeSH Terms

Conditions

Post-Acute COVID-19 SyndromeCOVID-19Fatigue

Interventions

Rehabilitation

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesPost-Infectious DisordersChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Irene Torres Sánchez, PhD

    Universidad de Granada

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PT, PhD, Principal Investigator

Study Record Dates

First Submitted

January 28, 2025

First Posted

February 7, 2025

Study Start

February 3, 2025

Primary Completion

July 31, 2025

Study Completion

July 31, 2025

Last Updated

January 26, 2026

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations